We evaluated nine semi-transparent plastic window-tinting films for their ability to block ultraviolet A (UVA) and infrared (IR) radiation and transmit therapeutic blue light (400-520 nm) for treating jaundiced newborns. For indoor testing, three light sources (TL/52 special blue fluorescent, Black Light UVA and IR heat lamps) were positioned above each film and measured successively using a thermocouple thermometer, UVA radiometer and blue light irradiance meter, placed below each film. For outdoor testing, the same setup was used with the sun at zenith and a cloudless sky. Compared with unfiltered radiation, blue light transmission through films ranged from 24 to 83%, UVA transmission was 0.1-7.1% and reductions in IR heat were 6-12 C and 5-10 C for heat lamp and sun, respectively. The data suggest that most of the relatively low-cost window-tinting films tested can effectively reduce sunlight UV and IR and offer a range of significant attenuations of therapeutic blue light.
Introduction
Sunlight phototherapy (PT) has been investigated as a treatment for hyperbilirubinemia because of its ability to reduce jaundice and serum total bilirubin levels in infants with hyperbilirubinemia [1] [2] [3] . However, direct sunlight is undesirable for treatment because it has a number of significant clinical and practical disadvantages [4] . For instance, harmful ultraviolet (UV) radiation (100-400 nm) in sunlight can seriously and permanently damage human skin [5] . Furthermore, sunlight also contains warming infrared (IR) radiation, which can cause hyperthermia and dehydration with insufficient cooling, especially in vulnerable neonates [6] . For these reasons, the American Academy of Pediatrics does not recommend its use for treating hyperbilirubinemia [7] . Mitigating these risks is likely to make sunlight safe and effective as a low-cost alternative to artificial light PT. Technological methods using pigments, coatings and films exist for blocking UV and IR radiation, and some will allow transmission of desirable portions of the solar energy spectrum. One innovation (already used in vehicles and buildings) is the application of semi-transparent plastic tinting films to windows. However, it is not known if any of these films would permit the transmission of sufficient therapeutic levels of blue light (400-520 nm) necessary to treat hyperbilirubinemia in newborns. This study investigates nine such films for their blocking ability of UV and IR radiation and the transmission of therapeutic blue light to determine the feasibility of using any of the films for sunlight PT. Table 1 . Presently, Solutia, Inc. (St Louis, MO) owns these brands. The retail price of the films tested range from US $0.50 (for M-type film) to $2.00 (for S-type film) per 30 Â 30 cm (or 1 sq. ft.).
Materials and Methods

Films
Laboratory Bench Tests
Because the radiation properties of sunlight cannot be easily reproduced in the laboratory by any one light source, three light sources were used for the bench tests (Fig. 1) . For IR testing, a reflector IR heat lamp (115-125 V, 250 W, General Electric, Fairfield, CT) powered with 80VAC from a Variac transformer was clamped to a laboratory stand 23 cm (a) above a rectangular wire film support positioned 7.5 cm (b) above a thermocouple thermometer (Type K, EA11A, Extech Instruments, Melrose, MA) that was placed 2.5 cm (c) above an insulating layer of 1-cm polyester batten and 5-cm thick polystyrene foam. The heating effect of the lamp, with no film present, was measured. Temperatures were recorded as C. Ambient temperature was kept constant. For UVA testing, a black light fluorescent lamp (F15T8-BLB, General Electric) with a spectral range of 315-400 nm was clamped to the laboratory stand at a 2-cm distance (a) above the film support with 0-cm distance (b) from the film to the meter. UVA intensity was measured as mW/cm 2 using a UVA meter (Goldilux Radiometer/Photometer with a GAP-1 The t ½ is the number of minutes required for the bilirubin concentration to decrease to half its original value.
Probe, Oriel Instruments, Stratford, CT), with the top of the photometer at 2.5 cm (c) above the insulating layer. This meter has a spectral sensitivity range of 315-400 nm, with peak sensitivity at 365 nm. For therapeutic blue light (spectral range of 400-520 nm) testing, a fluorescent lamp (TL 20W/52, Philips Electronics, Amsterdam, The Netherlands) fitted with a Clip-On Reflector (3M Inc., Minneapolis, MN) was clamped to the laboratory stand 23 cm (a) above the film support and a 23-cm distance (b) from film to meter. Light intensity (irradiance) was measured as mW/cm 2 /nm, with the top of the meter 2.5 cm above the insulating layer (c) using a BiliBlanket Meter II (GE HealthCare Technologies, Waukesha, WI), which has a spectral sensitivity range of 400-520 nm and peak sensitivity at 450 nm. Light intensity (irradiance) is a measure of radiometric flux per unit area (or flux density). It is typically expressed as W/cm 2 (watts per square centimeter) or mW/cm 2 /nm (microwatts per square centimeter per nanometer) by clinically used irradiance meters.
For each indoor bench test, the appropriate lamp was first powered on and allowed to equilibrate for 30 min. The appropriate detector was then placed at the center of the radiation footprint and the control response level (i.e., no film) was recorded. Without moving the detector, various films (22 Â 28-cm sheets), with their protective liners attached, were placed in succession on the film support, with the liner facing the lamp. The filtered radiation intensity was then recorded.
For outdoor sunlight testing, a similar experimental procedure was used, except that the lamps were replaced by sunlight at zenith (11:00-14:00 hr) in a cloudless sky on a roof at the Stanford University Medical Center (latitude: 37 26 0 08 00 N; longitude: 122 10 0 26 00 W). The experimental setup was shielded as much as possible from air currents, without interfering with sunlight delivery. Ambient temperatures were also recorded.
Determinations of t ½
The method and calculations for the determination of t ½ (min) for bilirubin photodestruction to diazonegative compounds were performed as previously described [8] . In summary, sets of (n ¼ 3) hematocrit tubes containing 25 ml of a bilirubin/human serum albumin (BR/HSA, 25 mg/dl/4% HSA in buffer) solution were exposed at 37 C to filtered sunlight. The remaining BR concentrations were quantitated using a diazo-reaction assay. The rate of BR photodegradation (t 1/2 ) was then determined through interpolation of plotted % BR degraded vs. time (min). We found that the t 1/2 s (efficacy) for a number of artificial light PT devices ranged from 16 to 67 min (in Table 3 
Results and Discussion
The results of testing the films with the three types of radiation are shown in Table 1 , with the data arranged in order of increasing %T of therapeutic blue light (range ¼ 33-83%) relative to unfiltered lamp light. The sunlight %T values for the films were similar, but relatively lower (range: 24-79%) than for lamplight. This is likely due to the meter's response to the broader-spectrum and higher- Bench test system used for evaluating samples of window-tinting films. The setup consists of a light source (IR, UVA or blue lamp) clamped separately to a laboratory stand, or the sun, under which a wire frame is positioned to support the 22 Â 28-cm sheets of film. To make the measurements, each detector (i.e., a thermocouple thermometer, a UVA photometer or a blue light irradiance meter) was placed in turn on the insulating layer so that its sensor was located 2.5 cm above the insulation. For IR, UVA, Blue lamps and sun, the distances for (a) were 23, 2, 23 cm and infinity; (b) were 19, 0, 23 and 5 cm and (c) were all 2.5 cm. emission peak (>600 nm) of sunlight compared with the narrow-spectrum and lower-emission peak (450 nm) of the specialized TL/52 blue light lamp [8, 9] . Blue light irradiance from unfiltered sun at zenith ranges from $100 to 150 mW/cm 2 /nm in a cloudless sky, but only <25 mW/cm 2 /nm in an overcast sky (measured with the BiliBlanket II Meter, unpublished observations). Significant attenuation of blue light might be desirable depending on geographical latitude, season and the time of day. Thus, under clear skies, when an attenuated transmission of blue light is desirable, Gila Titanium film would be a good choice, because it transmits only 33% (or potentially up to 33-50 mW/cm 2 /nm) of therapeutic blue light [10] . However, under overcast sky, this film transmits a barely effective irradiance of 8 mW/cm 2 / nm. When maximum blue light transmission is desired (e.g., under an overcast sky), the Air Blue 80 film (79%T) would still transmit $20 mW/cm 2 / nm, which is comparable with standard PT used in developing [11, 12] and developed countries [13] . The present data suggest that most of the tested windowtinting films can effectively reduce sunlight UV and IR and offer a range of clinically significant attenuations of therapeutic blue light.
Except for Gila Platinum film, UVA transmission for the films was <1%. Therefore, UV radiation is effectively blocked by all but one of the tested films. Because UVA light (315-400 nm) is more likely to pass through organic films than UVB (280-315 nm) or UVC (100-280 nm) light, it can be inferred that these forms of UV irradiation will also be blocked.
IR measurements show the greatest difference in magnitude between lamp-and sunlight. However, there also exists a corresponding relationship for this parameter, with the sunlight values being lower than lamplight by an average of 3 C. It is possible that air currents or the broader sunlight IR spectrum [9] affected the results. Nonetheless, the data show that all films reduced heat transmission, and that the metalized (M) films were more effective at reducing temperature compared with the spectrally selective transition metal oxynitride (S) films. Relative temperature reduction is important for designing clinical field studies. In areas where sunshine is abundant, but ambient temperatures are relatively low (e.g., at high altitudes or latitudes), films with sufficient heat transmission would probably be needed to maintain patient thermostasis.
The t ½ data demonstrated the effectiveness of sunlight toward bilirubin degradation. Unfiltered Stanford sunlight produced a very short t ½ of 4 min, whereas the filtered light showed a range of longer t ½ s (range: 4.7-10.2 min). However, compared with our earlier results [8] , even the film with the longest t ½ (Gila Titanium, t ½ ¼ 10.2 min) was more effective than the artificial electric light devices, such as the BiliBed [Medela, McHenry, IL (t ½
Because the films were studied with their liners (which protect the sticky or window application side from dust) in place, we also tested if there was polarity to the films, but no difference in %T was detected whether the active layer of the films or the liner faced the light source (data not shown). Consequently, liners were left attached to serve as an additional protective layer when panels of the film were handled and studied, or installed over canopies, and exposed to sun, rain, wind and dust. We recommend that the films be mounted with the liner side facing the sun so that the active layer is maximally protected from being damaged.
The ideal sunlight PT film should: (i) block UV radiation to <1% that of unfiltered sunlight ($2000 mW/cm 2 ), (ii) block IR sufficiently to maintain patient thermostasis, (iii) transmit sufficient level of therapeutic blue light and (iv) be transparent to facilitate visibility of the patient for purposes of clinical management. Optimally effective blue light irradiance levels have not yet been established, but it is believed that levels between 30 and 70 mW/cm 2 /nm (as measured with the BiliBlanket Meter II) constitute intensive and effective PT for jaundiced newborns [7] . Crigler-Najjar syndrome patients are frequently treated with $100 mW/cm 2 /nm [14] . The present data suggest that most of the tested window-tinting films can effectively reduce sunlight UV and IR and offer a range of clinically significant attenuations of therapeutic blue light.
Data from the developing world suggest that severe newborn jaundice and its progression to kernicterus is a leading cause of newborn deaths and disabilities [15] . Many of these same locales are underserved clinical settings, where electrical energy is not reliably available or where hospitals cannot afford the purchase of effective PT devices [3] . For example, in Nigeria, there is a shortage of modern PT units and only intermittent electric power is available to run these devices [13, 16] . Thus, in such locales, development of inexpensive sunlight PT methods might alleviate both cost and health burdens. If one or more of the films tested in this study can be shown to be clinically safe and effective, more patients might receive lifesaving PT treatment and avoid serious lifelong health consequences (i.e., kernicterus) or death. Clinical studies are in progress to confirm the safety and efficacy of some of these films for sunlight PT [10] . Therefore, the use of window-tinting films might be a viable option for advancing the delivery of safe and effective PT to patients in these areas.
We envision that the applicability of the films to physical treatment facility configurations will be 3-fold (Fig. 2): basket, which is placed in sunlight, filtered with a relatively small panel of film ($60 Â 90 cm) draped over a simple (wire) frame (Fig. 2A) ; 2. Portable group or community treatment facility (Fig. 2B ). This type of configuration is presently being studied in Nigeria, where the mothers, seated in comfortable seats, can hold and bond with their babies as well as nurse, while interacting with other mothers and infants [10] ; 3. Permanent hospital-based treatment facility. This type of facility is economically more expensive and involves the building of a more or less permanent PT facility with optimal orientation to the daily and seasonal course of the sun [17] and maximum and optimally placed overhead and vertical windows covered with carefully selected window-tinting film attached to or affixed next to the inside window surfaces. Moreover, its non-window surfaces should be painted white to maximally reflect the incoming light throughout the room. An advantage of a permanent structure is the ability to receive sunlight PT without disruption of care during rain.
A significant limitation of sunlight PT is that sunlight radiation levels can and do change hourly, daily and seasonally [3] . It is therefore likely that sunlight PT will be most practical in medical facilities near the equator, where sunlight is relatively plentiful and intense, and where ambient air temperatures are sufficiently high to keep the nearly naked patient's body temperature within safe levels. It may also be a sustainable alternative PT option for worldwide application.
Finally, filtered sunlight PT could be a particularly powerful therapeutic tool when it is combined with solar panel energy-capturing/storage systems and efficient light-emitting diode-based PT devices for treatment, when sufficient sunlight is not available [18] . 
